We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$43.9B
AUM Growth
+$2.15B
Cap. Flow
+$941M
Cap. Flow %
2.15%
Top 10 Hldgs %
38.78%
Holding
1,752
New
25
Increased
441
Reduced
297
Closed
24

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$166M
2
MU icon
Micron Technology
MU
+$148M
3
FERG icon
Ferguson
FERG
+$131M
4
AMD icon
Advanced Micro Devices
AMD
+$107M
5
GEV icon
GE Vernova
GEV
+$94.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$262M
2
TMUS icon
T-Mobile US
TMUS
+$167M
3
VZ icon
Verizon
VZ
+$114M
4
NFLX icon
Netflix
NFLX
+$84.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$74.2M

Sector Composition

Rank Sector Weight
1 Technology 34.5%
2 Healthcare 13.82%
3 Communication Services 13.35%
4 Financials 13.33%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
26
Capital One
COF
$128B
$260M 0.59%
1,073,550
+11,553
+1% +$2.57M
GS icon
27
Goldman Sachs
GS
$300B
$259M 0.59%
294,221
+7,729
+3% +$6.31M
AMD icon
28
Advanced Micro Devices
AMD
$776B
$257M 0.59%
1,202,094
+478,214
+66% +$107M
MA icon
29
Mastercard
MA
$502B
$257M 0.59%
449,648
-2,090
-0.5% -$1.17M
IBM icon
30
IBM
IBM
$211B
$255M 0.58%
860,199
+191,267
+29% +$57.3M
ISRG icon
31
Intuitive Surgical
ISRG
$125B
$238M 0.54%
420,593
+18,697
+5% +$9.95M
PFE icon
32
Pfizer
PFE
$143B
$229M 0.52%
9,193,713
+706,426
+8% +$17.8M
QCOM icon
33
Qualcomm
QCOM
$155B
$228M 0.52%
1,330,021
+158,710
+14% +$27.2M
BMY icon
34
Bristol-Myers Squibb
BMY
$133B
$214M 0.49%
3,967,121
-102,790
-3% -$4.94M
CAH icon
35
Cardinal Health
CAH
$53.9B
$210M 0.48%
1,021,940
+5,608
+0.6% +$1.06M
IDXX icon
36
Idexx Laboratories
IDXX
$44.1B
$209M 0.48%
309,380
+134,493
+77% +$91.6M
DIS icon
37
Walt Disney
DIS
$167B
$200M 0.46%
1,759,843
+237,699
+16% +$26.2M
WELL icon
38
Welltower
WELL
$169B
$198M 0.45%
1,065,357
+98,879
+10% +$18.5M
UNH icon
39
UnitedHealth
UNH
$376B
$196M 0.45%
593,104
+32,770
+6% +$11.1M
AMGN icon
40
Amgen
AMGN
$208B
$187M 0.43%
572,145
+86,723
+18% +$27.5M
ECL icon
41
Ecolab
ECL
$78.1B
$186M 0.43%
709,949
-25,898
-4% -$6.9M
NET icon
42
Cloudflare
NET
$99B
$185M 0.42%
936,921
+117,155
+14% +$24.8M
HCA icon
43
HCA Healthcare
HCA
$87.2B
$179M 0.41%
384,421
-29,487
-7% -$13.7M
MCK icon
44
McKesson
MCK
$100B
$178M 0.41%
217,605
+74,287
+52% +$60.6M
STX icon
45
Seagate
STX
$194B
$176M 0.4%
638,613
+12,640
+2% +$3.28M
IQV icon
46
IQVIA
IQV
$38.7B
$176M 0.4%
779,128
+315,883
+68% +$68.7M
AXP icon
47
American Express
AXP
$227B
$175M 0.4%
473,027
+1,972
+0.4% +$706K
APP icon
48
Applovin
APP
$133B
$169M 0.38%
250,224
+132,029
+112% +$83.2M
SPG icon
49
Simon Property Group
SPG
$74.4B
$167M 0.38%
902,219
-31,246
-3% -$5.68M
LRCX icon
50
Lam Research
LRCX
$367B
$167M 0.38%
974,684
-443,943
-31% -$69M

Similar funds

KBC Group's Q4 2025 Portfolio in Review

As of Q4 2025, KBC Group held 1,752 positions worth $43.9B, up 5.2% from $41.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 2.8%. KBC Group opened 25 new positions and exited 24, leaving the 1,752-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Communication Services.

  • KBC Group's largest Q4 2025 buy was Qnity Electronics Inc: 149,289 shares worth $12.2M.
  • KBC Group added most to Abbott in Q4 2025, an estimated $166M increase.
  • KBC Group's biggest Q4 2025 reduction was T-Mobile US, cutting an estimated $167M.
  • KBC Group fully exited AbbVie in Q4 2025, selling an estimated $262M.
  • KBC Group's ten largest holdings make up 39% of its $43.9B portfolio in Q4 2025.
  • KBC Group opened 25 new positions and closed 24 in Q4 2025.
  • KBC Group's portfolio value rose 5.2% quarter-over-quarter to $43.9B.

Based on KBC Group's 13F filing for Q4 2025, filed 26 Jan 2026.